[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-111846-en":3,"doc-seo-111846-105":28,"detail-sidebar-cat-0-en-105":88},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":4,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":13,"seo_description":14,"update_tm":27,"read_time":11},111846,962075114765,"Quinn","https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd",8,"Research & Report","Audit Committee Minutes of Meeting - March 26, 2025 - Record of Approval March 21, 2025","Audit Committee minutes document the meeting held on March 26, 2025 at 2:33 p.m. in the Board Room. Present members and advisors are listed, followed by agenda discussions on the Semi-Annual Integrity Vice Presidency report for Fiscal Year 2025 (Quarters 1–2) and the IFC Portfolio and Risk Report FY25 Q2. The committee prepares a report to the Board for each discussed item and adjourns at 5:22 p.m. Separately, approval endorsements occur on an absence-of-objection basis on March 21, 2025, including MIGA FY25 H1 Risk, Capital Adequacy and Limits Review.","Public Disclosure Authorized Public Disclosure Authorized  \nAUDIT COMMITTEE  \nFROM: The Committee Secretary  \nMinutes of Meeting held on Wednesday, March 26, 2025 at 2:33 p.m. in the Board Room  \nPresent  \nCommittee Members:  \nA. Almulla (Chair)  \nA. Alroomi (Alternate)  \nP. Bonmartin (Alternate)  \nM. Gurstein (Temporary Alternate)  \nS. Lambasara (Alternate)  \nL. Magagula (Alternate)  \nS. Rawet  \nS. Suter (Temporary Alternate)  \nOther Executive Directors, Alternates, Senior Advisors and Advisors  \nR. Alsinaidi  \nE. Amor  \nV. Anicatt  \nG. Baldivieso  \nL. Engozogo Mba  \nP. Fonseca  \nM. Guido  \nG. Horvath  \nL. Huang  \nS. Khan  \nR. Kachur  \nM. Kratochvil  \nM. Krukowski  \nA. Maleki  \nS. Maluck  \nF. Mayorga  \nE. Sta. Ana  \nE. Sycheva  \nA. Tsuji  \nM. Warren  \nY. Yan  \nOfficers and Staff  \nA. Bacarese  \nS. Bwana  \nC. Kane Janus  \nR. Delonis  \nM. Diagne  \nM. Donolo  \nK. Eichinger  \nT. Fayose  \nJ. Frazier  \nF. Galizia  \nM. Gouled  \nP. Lombardo  \nL. Miller  \nO. Nakoulima  \nF. Siddiqui  \nG. Tanyi  \nH. Murai (Acting Committee Secretary)  \nSemi-Annual Report of the Integrity Vice Presidency to the Audit Committee-Fiscal Year 2025, Quarters 1-2 (July 1 – December 31, 2024)  \n1. The Committee discussed the document entitled “Semi-Annual Report of the Integrity Vice Presidency to the Audit Committee-Fiscal Year 2025, Quarters 1-2 (July 1 – December 31, 2024)”(AC2025-0012/1). A report from the Committee to the Board was prepared.  \nIFC Portfolio and Risk Report FY25 Q2  \n2. The Committee discussed the document entitled “IFC Portfolio and Risk Report FY25 Q2”(AC2025-0013). A report from the Committee to the Board was prepared.  \nAdjournment  \n3. The meeting adjourned at 5:22 p.m.  \nThe following item(s) have been approved/endorsed  \nby the Audit Committee on an Absence of Objection Basis  \non March 21, 2025  \nMIGA FY25 H1 Risk, Capital Adequacy and Limits Review (Revision)  \n1. On March 21, 2025, the Committee endorsed the document entitled “MIGA FY25 H1 Risk, Capital Adequacy and Limits Review (Revision) (AC2025-0014) .","cbCaidOHYVKatlAh","https://ap.wps.com/l/cbCaidOHYVKatlAh","pdf",166174,1,3,"English","en",105,"# Minutes of Meeting\n## Meeting details and attendance\n## Agenda item reviews\n## Adjournment\n# Items Approved on Absence of Objection Basis\n## March 21, 2025 approvals","[{\"question\":\"When and where was the Audit Committee meeting held?\",\"answer\":\"The meeting was held on Wednesday, March 26, 2025 at 2:33 p.m. in the Board Room.\"},{\"question\":\"Which key reports were discussed during the meeting?\",\"answer\":\"The committee discussed the Semi-Annual Report of the Integrity Vice Presidency to the Audit Committee for FY2025 Q1–Q2, and the IFC Portfolio and Risk Report FY25 Q2.\"},{\"question\":\"What items were approved or endorsed outside the meeting date?\",\"answer\":\"On an absence of objection basis on March 21, 2025, the committee endorsed the MIGA FY25 H1 Risk, Capital Adequacy and Limits Review (Revision).\"}]",1784491974,{"code":4,"msg":29,"data":30},"ok",{"site_id":24,"language":23,"slug":31,"title":13,"keywords":32,"description":14,"schema_data":33,"social_meta":83,"head_meta":85,"extra_data":87,"updated_unix":27},"audit-committee-minutes-of-meeting-march-26-2025-record-of-approval-march-21-2025","",{"@graph":34,"@context":82},[35,51,65],{"@type":36,"itemListElement":37},"BreadcrumbList",[38,42,46,48],{"item":39,"name":40,"@type":41,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":43,"name":44,"@type":41,"position":45},"https://docshare.wps.com/document/","Document",2,{"item":47,"name":12,"@type":41,"position":21},"https://docshare.wps.com/document/research-report/",{"item":49,"name":13,"@type":41,"position":50},"https://docshare.wps.com/document/audit-committee-minutes-of-meeting-march-26-2025-record-of-approval-march-21-2025/111846/",4,{"url":49,"name":13,"@type":52,"author":53,"headline":13,"publisher":55,"fileFormat":58,"inLanguage":23,"description":14,"dateModified":59,"datePublished":59,"encodingFormat":58,"isAccessibleForFree":60,"interactionStatistic":61},"DigitalDocument",{"name":9,"@type":54},"Person",{"url":39,"name":56,"@type":57},"DocShare","Organization","application/pdf","2026-07-19",true,{"@type":62,"interactionType":63,"userInteractionCount":4},"InteractionCounter",{"@type":64},"ViewAction",{"@type":66,"mainEntity":67},"FAQPage",[68,74,78],{"name":69,"@type":70,"acceptedAnswer":71},"When and where was the Audit Committee meeting held?","Question",{"text":72,"@type":73},"The meeting was held on Wednesday, March 26, 2025 at 2:33 p.m. in the Board Room.","Answer",{"name":75,"@type":70,"acceptedAnswer":76},"Which key reports were discussed during the meeting?",{"text":77,"@type":73},"The committee discussed the Semi-Annual Report of the Integrity Vice Presidency to the Audit Committee for FY2025 Q1–Q2, and the IFC Portfolio and Risk Report FY25 Q2.",{"name":79,"@type":70,"acceptedAnswer":80},"What items were approved or endorsed outside the meeting date?",{"text":81,"@type":73},"On an absence of objection basis on March 21, 2025, the committee endorsed the MIGA FY25 H1 Risk, Capital Adequacy and Limits Review (Revision).","https://schema.org",{"og:url":49,"og:type":84,"og:title":13,"og:site_name":56,"og:description":14},"article",{"robots":86,"canonical":49},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":89},[90,94,98,102,107,112,117,120,125,128,132],{"id":20,"doc_module":4,"doc_module_name":44,"category_name":91,"show_sort_weight":92,"slug":93},"Story & Novel",90,"story-novel",{"id":45,"doc_module":4,"doc_module_name":44,"category_name":95,"show_sort_weight":96,"slug":97},"Literature",80,"literature",{"id":50,"doc_module":4,"doc_module_name":44,"category_name":99,"show_sort_weight":100,"slug":101},"Exam",70,"exam",{"id":103,"doc_module":4,"doc_module_name":44,"category_name":104,"show_sort_weight":105,"slug":106},5,"Comic",60,"comic",{"id":108,"doc_module":4,"doc_module_name":44,"category_name":109,"show_sort_weight":110,"slug":111},6,"Technology",50,"technology",{"id":113,"doc_module":4,"doc_module_name":44,"category_name":114,"show_sort_weight":115,"slug":116},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":44,"category_name":12,"show_sort_weight":118,"slug":119},30,"research-report",{"id":121,"doc_module":4,"doc_module_name":44,"category_name":122,"show_sort_weight":123,"slug":124},9,"Religion & Spirituality",20,"religion-spirituality",{"id":123,"doc_module":4,"doc_module_name":44,"category_name":126,"show_sort_weight":123,"slug":127},"World Cup","world-cup",{"id":129,"doc_module":4,"doc_module_name":44,"category_name":130,"show_sort_weight":129,"slug":131},10,"Lifestyle","lifestyle",{"id":133,"doc_module":4,"doc_module_name":44,"category_name":134,"show_sort_weight":103,"slug":135},19,"General","general"]